NEWS RELEASE
MARCH 31, 1999
Pyng Technologies Update
VANCOUVER, BRITISH COLUMBIA--Michael W. Jacobs, President, Pyng
Technologies Corp. and Pyng Medical Corp. is pleased to announce
the following
Pyng Medical Corp. personnel have had the opportunity to train 23
Instructors at the Joint Operations Medical Training Center,
School and US Army JFK Special Warfare Center. According to the
Director, Medical Research and Development, United States Army
Special Operations Command, Pyng Medical Corp's training
procedures and professional approach to delivering instruction on
the F.A.S.T 1 System for Adult Intraosseous Infusion during the
time frame allotted was well received by the JFK Instructors. The
training session introduced the F.A.S.T 1 System, provided "hands
on" use of the System in cadavers, as well as provide the
Instructors at JFK the opportunity to discuss, in detail, the
benefits of Intraosseous Infusion in a battlefield environment
utilizing the F.A.S.T 1 System. The US Army JFK Special Warfare
School and Center is the lead center for training Special
Operations Command medics throughout the US Military Forces.
Pyng Medical Corp.also has had the opportunity to present the
F.A.S.T 1 System at the EMS Today Conference in Denver, March 24
through 27th 1999. Several opportunities were presented to Pyng
Medical for the distribution of the F.A.S.T 1 System across
America. Michael Jacobs, President, who was present at the
conference, has agreed to start initial negotiations with several
medical product distributors that meet Pyng Medical Corp.criteria
for proper exposure to the pre-hospital and emergency hospital
market place in their regional zones. Such criterion includes
sales staff trained in emergency medical procedures and who
concentrate their sales efforts in the emergency hospital and
pre-hospital medical market place. The distributors demonstrated
abilities to work closely with appropriate contacts in the
emergency market place as well as having the abilities to
warehouse, stock, and ship in a timely manner to service the
anticipated demand are important issues to Pyng Medical Corp. Mr.
Jacobs also had the opportunity to meet with Operations Managers
and Supervisors of American Medical Response, America's largest
ambulance service as well as the Deputy Commander, United States
Public Health Service, National Medical Response Team. Pyng
Medical Corp. is now concentrating all efforts to bring the
F.A.S.T 1 System to market as we gear up for mass production.
Field trials on the F.A.S.T 1 have provided a great deal of input
for product improvements as well as provide proof positive as to
the effectiveness of the F.A.S.T 1 System for Adult Intraosseous
Infusion to gain vascular access in emergency situations when
conventional I.V. methods fail.
-30-
FOR FURTHER INFORMATION PLEASE CONTACT:
Pyng Technologies Corp.
Michael W. Jacobs
1-800-349-7964
Website: www.pyng.com
The VSE has neither reviewed nor approved of the contents of this
news release.
|
